Capital Flow Monitor · Sponsors · CIK 2077887
Ascend SMG Co-Invest 3, L.P.
C/O ASCEND PARTNERS, NEW YORK, NY, 10022 · 800-370-7815
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Ascend SMG Co-Invest GP, L.P. — Executive Officer, New York, NY
-
N/A Ascend Capital Partners UGP, LLC — Executive Officer, New York, NY
1 other raise
- Ascend Capital Partners Fund II, L.P. $790.8M of $860.0M · 91.9%
-
In Seon Hwang — Executive Officer, New York, NY
3 other raises
- Ascend Capital Partners Fund II-FF, L.P. $790.8M of $860.0M · 91.9%
- Ascend Capital Partners Fund II-A, L.P. $790.8M of $860.0M · 91.9%
- Ascend Capital Partners Fund II, L.P. $790.8M of $860.0M · 91.9%
-
Richard Park — Executive Officer, New York, NY
4 other raises
- TownHome Health Inc. $860K of $2.0M · 43.0%
- Ascend Capital Partners Fund II-FF, L.P. $790.8M of $860.0M · 91.9%
- Ascend Capital Partners Fund II-A, L.P. $790.8M of $860.0M · 91.9%
- Ascend Capital Partners Fund II, L.P. $790.8M of $860.0M · 91.9%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.